Official title: To provide for the imposition of sanctions with respect to forced organ harvesting within the People’s Republic of China, and for other purposes.
Introduced February 24, 2025 by Scott Perry · Last progress May 6, 2025
The bill strengthens U.S. accountability and transparency to combat alleged forced organ harvesting and protects humanitarian aid, while trading off increased diplomatic friction, risks to scientific collaboration, business and legal burdens, and additional reporting costs.
Perpetrators and facilitators of involuntary organ harvesting (and those complicit) will be blocked from U.S. visas, entry, property, and transactions, reducing their ability to benefit from or access the U.S. system and increasing accountability for human-rights abuses.
U.S. policymakers, researchers, and the public will receive a consolidated unclassified report and a public list of alleged perpetrators and U.S. grant relationships within one year, improving oversight, transparency, and evidence-based policy or advocacy.
Humanitarian organizations delivering food, medicine, and transport will be explicitly exempted from penalties, protecting ongoing delivery of aid and medical supplies from unintended sanctions-related disruptions.
Researchers, scientists, and patients could see slowed or curtailed collaborations with PRC researchers—potentially delaying legitimate transplant research and harming patient outcomes—because restrictions and disclosure requirements could chill partnerships.
State governments, taxpayers, and international partners could face heightened geopolitical tension and retaliatory measures if sanctions or an 'atrocity' designation provoke PRC responses, complicating cooperation on other global issues.
Small businesses, universities, hospitals, and financial institutions may suffer asset freezes, transaction bans, and contractual disruptions when persons or entities are designated, causing commercial and operational harm.
Based on analysis of 6 sections of legislative text.
Requires a US sanctions/visa regime and reporting on PRC involuntary organ harvesting, lists alleged perpetrators, and forbids sanctioning imports under this Act.
Creates U.S. policy to oppose state‑sponsored involuntary organ harvesting in the People’s Republic of China and directs targeted U.S. measures in response. Requires the President to publish and update a list of foreign persons credibly alleged to have knowingly participated in or facilitated involuntary organ harvesting in China and to impose blocking sanctions, visa bans, and related penalties on listed persons, with narrow humanitarian and intelligence exceptions and a five‑year sunset for the sanction authority. Also directs a State Department report, in consultation with HHS and NIH, on PRC organ transplant practices, counts of transplants and voluntary donors, U.S. research grants supporting PRC transplantation work, and an assessment whether persecution of Falun Gong rises to an “atrocity.” Prohibits using the Act’s sanction authorities to target imports of goods and defines “goods.”